Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HIV DNA vaccine topical - Genetic Immunity

Drug Profile

HIV DNA vaccine topical - Genetic Immunity

Alternative Names: DermaVir Patch; LC002

Latest Information Update: 26 Dec 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Genetic Immunity LLC
  • Developer Genetic Immunity; Karolinska Institute; National Institute of Allergy and Infectious Diseases; Virostatics
  • Class AIDS vaccines; DNA vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II HIV-1 infections

Most Recent Events

  • 18 Dec 2018 HIV DNA vaccine topical is licensed for marketing to Pharmadis in Russia and Commonwealth of Independent States
  • 18 Dec 2018 Genetic Immunity plans to submit an IND application with the USFDA for HIV-1 infections
  • 18 Dec 2018 Genetic Immunity plans a clinical trial for HIV-1 infections in Russia in first half of 2019
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top